mitogen-activated protein kinase (mapk) pathway inhibitor sch772984 (ApexBio)
90
Structured Review
ApexBio
mitogen-activated protein kinase (mapk) pathway inhibitor sch772984
Mitogen Activated Protein Kinase (Mapk) Pathway Inhibitor Sch772984, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mitogen-activated+protein+kinase+(mapk)+pathway+inhibitor+sch772984/akt+inhibitor+wortmannin/pm39709027-65-2-17
Average 90 stars, based on 1 article reviews
Mitogen Activated Protein Kinase (Mapk) Pathway Inhibitor Sch772984, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mitogen-activated+protein+kinase+(mapk)+pathway+inhibitor+sch772984/akt+inhibitor+wortmannin/pm39709027-65-2-17
Average 90 stars, based on 1 article reviews
mitogen-activated protein kinase (mapk) pathway inhibitor sch772984 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Modulation of the local angiotensin II: Suppression of ferroptosis and radiosensitivity in nasopharyngeal carcinoma via the HIF-1α-HILPDA axis. Article Snippet: Purpose: Radiotherapy presents a curative approach for nasopharyngeal carcinoma (NPC); however, the cellular radiosensitivity heterogeneity limits its efficacy.. Thus, investigating the specific mechanisms of radioresistance in NPC is crucial for identifying and employing effective radiosensitizing agents to enhance treatment success.. Methods and Materials: Radioresistant NPC cell lines HONE1-RR and SUNE1-RR were established. |